IDH3α overexpression in cancers like uterine cervical cancer (UCC) and lung adenocarcinoma (LUAD) contributes to chemoimmunotherapy resistance by creating an acidic tumor microenvironment (TME) that impairs immune cell function, especially CD8+ T cells, and inhibits the cGAS–STING pathway. The gene discussed is IDH3A; the disease is cancer.